lobbying_activities: 2642628
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2642628 | 445214e9-2d51-42b8-b5c0-c239a80ce9e7 | 2A | KNIGHT CAPITOL CONSULTANTS | 40036301 | REGENXBIO | 2021 | second_quarter | PHA | Possible legislation which may affect Food and Drug Administration review of biologic products (no specific bill) | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-07-17T21:44:39.107000-04:00 |